Workflow
Amylyx Pharmaceuticals, Inc. (AMLX) Avexitide Acquisition Conference Call Transcript
2024-07-10 18:23
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Avexitide Acquisition Conference Call July 10, 2024 8:00 AM ET Company Participants Lindsey Allen - Head of Investor Relations and Communications Justin Klee - Co-Chief Executive Officer Joshua Cohen - Co-Chief Executive Officer Camille Bedrosian - Chief Medical Officer James Frates - Chief Financial Officer Conference Call Participants Corinne Jenkins - Goldman Sachs Michael DiFiore - Evercore ISI Graig Suvannavejh - Mizuho Securities Charlie Yang - Bank of Americ ...
The Greenbrier mpanies
Counterpoint Research· 2024-07-10 13:46
Welcome to the Greenbrier Company's third quarter of fiscal 2024 earnings conference call. Following today's presentation, we will conduct a question and answer session. Each analyst should limit themselves to one question with a follow-up if needed. Until that time, all lines will be in a listen-only mode. At the request of the Greenbrier Company, this conference call is being recorded for instant replay purposes. At this time, I'd like to turn the floor over to Mr. Justin Roberts, Vice President and Treas ...
Indivior PLC (INDV) Business Update Call Transcript
2024-07-09 14:39
Indivior PLC (NASDAQ:INDV) Business Update Conference Call July 9, 2024 8:00 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Conference Call Participants Max Herrmann - Stifel Thibault Boutherin - Morgan Stanley Paul Cuddon - Deutsche Numis Chase Knickerbocker - Craig-Hallum Carl Byrnes - Northland Capital Markets Operator Good day, and thank you for standing by. Welcome to the Indivior Business Update Conference Call. At this time all participants are in listen-only mode. After the s ...
Devon Energy Corporation (DVN) Mergers & Aquisitions Conference - (Transcript)
2024-07-08 17:14
Devon Energy Corporation (NYSE:DVN) Mergers & Aquisitions Conference Call July 8, 2024 8:30 AM ET Company Participants Scott Coody - Vice President of Investor Relations Rick Muncrief - President and Chief Executive Officer Clay Gaspar - Executive Vice President and Chief Operating Officer Jeff Ritenour - Executive Vice President and Chief Financial Officer David Harris - Executive Vice President and Chief Corporate Development Officer Conference Call Participants Nitin Kumar - Mizuho Securities Neal Dingma ...
Brainstorm Cell Therapeutics Inc. (BCLI) Corporate Mid-Year Update on NurOwn Program (Transcript)
2024-07-08 14:12
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Corporate Mid-Year Update on NurOwn Program July 8, 2024 8:00 AM ET Company Participants Joyce Lonergan - LifeSci Advisors Chaim Lebovits - President and Chief Executive Officer Haro Hartounian - Executive Vice President, Chief Operating Officer Bob Dagher - Executive Vice President, Chief Medical Officer Conference Call Participants Jason McCarthy - Maxim Group David Bautz - Zachs Small Cap Research Operator Greetings and welcome to the Brainstorm Cell Therap ...
Tempur Sealy International, Inc. (TPX) Special Call Transcript
2024-07-08 13:10
Tempur Sealy International, Inc. (NYSE:TPX) Special Call July 8, 2024 8:00 AM ET Company Participants Aubrey Moore - Investor Relations Scott Thompson - Chairman, President & Chief Executive Officer Conference Call Participants Operator Good day, everyone and welcome to today's Tempur Sealy International Business Update Call. At this time, all participants are in a listen-only mode. Please note, this call is being recorded. I will be standing by if you should need any assistance. It is now my pleasure to tu ...
BofA Hartnett The ow Show Long Long Bond
Flywheel· 2024-07-04 06:35
BofA Hartnett The ow Show Long Long Bond ...
Gain Therapeutics, Inc. (GANX) Special Call Transcript
2024-07-01 14:13
Gain Therapeutics, Inc. (NASDAQ:GANX) Special Call Transcript July 1, 2024 8:30 AM ET Company Participants Apaar Jammu - Manager, Investor Relations Gene Mack - Chief Financial Officer & Interim Chief Executive Officer Conference Call Participants Operator Hello, all. Thank you for joining us today for Gain Therapeutics Corporate and Business Update Call. A transcript and replay of this call will be available on the Gain Therapeutics website. I would now like to pass this call over to Manager of Investor Re ...
20240628
安信香港· 2024-06-29 06:12
我们主要观点就是看到2023年收益崛起卢沃战争影响全球的粮食价格与化肥价格因此一直持续到2023年的产品价格开始下行周期 行业竞争开始加剧我们看到在这样一个大环境下我们认为在企业方面我也通过差异化的规定 以及做高端做高效的这种化肥产品才能保证它的一个开放率利润和一个价格那接下来我给您演讲给主要设备商这方面开始进行首先说一下大致的一个化肥行业化肥是用化学和物理的方式制成的一种还有一种或者多种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种种 像普通话给我们就比较包含淡肥淋肥加肥和复合肥的那个化肥可以说是农业生产最基础和最重要的一个物质投入它关系到我国农业的这个增产增效农民的这个输入 国家的粮食安全等等一句简单的话就怪扣的话就是化肥是粮食的粮食而下面这张图是我国化肥行业的这样一个失业数量从1980年开始到现在2023年这个化肥失业数量的一个表现 从数量上可以看到2015年是当中最重要的一个分水岭2015年中国 ...
base20240626
informs· 2024-06-27 13:39
提示一下 本次电话会议仅供符合国海证券投资者适当性管理要求的客户以及受邀客户使用国海证券不会因接收人收到本次会议相关通知或参加本次会议而释其为客户本次会议内容不构成任何投资建议据此作出的任何投资决策与国海证券国海证券员工或者关联机构无关本次会议只是转发国海证券已发布研究报告的部分观点仅反映国海证券研究人员于发布完整报告当日的判断 相关内容请以研究所已公开发布报告为准会议严禁录音或转发 任何人不得对本次会议的任何内容进行发布复制编辑改编转载播放展示或以其他任何方式非法使用本次会议的部分或者全部内容否则将承担相应的法律责任国海证券就此保留一切法律权利在任何情况下国海证券及其员工对使用本次会议信息或内容所引发的任何直接或间接损失概不负责市场有风险投资需谨慎 各位投资者大家晚上好我是国海证券飞银首席孙嘉庚那么那个非常高兴大家今天参加我们的讨论那么这个今天我们的这个主题呢就是coinbase因为这个我们近期其实也是刚刚覆盖了这个coinbase那么今天晚上我们的会议呢就是不会说这个简单的把这个报告从头到尾过一点那么我们更多的是带着几个问题吧 带着几个大家比较关心啊以及市场上比较关心的问题然后来呃一边一边探讨然后一边再把 ...